PAVM (PAVmed) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PAVM PAVmed Inc PAVM
32 GF Score
Price $4.92
GF Value $1.21
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is PAVmed Net Loan?

Net Loan only applies to banks and insurance companies.

PAVM
32GF Score
PAVmed Inc PAVM
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PAVmed (PAVM) Overvalued in 2026?

Based on GuruFocus' analysis, PAVmed stock appears to be overvalued. The current stock price of $4.92 is trading 306.6% above its estimated GF Value™ of $1.21. GuruFocus considers PAVmed to be Significantly Overvalued.

Key valuation signals for PAVM:

  • Net Loan:
  • GF Value™: $1.21 vs. price of $4.92 (306.6% above fair value)
  • GF Score™: 32/100 with 5 warning signs

No single metric tells the full story. See the PAVM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PAVmed Business Description

Other Exchanges 1P5:Germany
Address 360 Madison Avenue, 25th Floor, New York, NY, USA, 10017
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
32GF Score

Get the complete analysis for PAVM

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.92
Price
$1.21
GF Value